✦ LIBER ✦

Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection

✍ Scribed by Summa, Vincenzo; Petrocchi, Alessia; Bonelli, Fabio; Crescenzi, Benedetta; Donghi, Monica; Ferrara, Marco; Fiore, Fabrizio; Gardelli, Cristina; Gonzalez Paz, Odalys; Hazuda, Daria J.

Book ID: 115528142
Publisher: American Chemical Society
Year: 2008
Tongue: English
Weight: 262 KB
Volume: 51
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm800245z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery and Synthesis of HIV Integrase

Discovery and Synthesis of HIV Integrase Inhibitors: Development of Potent and Orally Bioavailable N-Methyl Pyrimidones

✍ Nizi, Emanuela; Muraglia, Ester; Crescenzi, Benedetta; Ferrara, Marco; Orvieto, 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 398 KB

Structure-based discovery of tipranavir

Structure-based discovery of tipranavir disodium (PNU-140690E): A potent, orally bioavailable, nonpeptidic HIV protease inhibitor

✍ Suvit Thaisrivongs; Joseph W. Strohbach 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 167 KB 👁 1 views

Efforts to develop therapeutically relevant HIV protease inhibitors as medicinal agents in confronting the AIDS crisis have been aided by the wealth of fundamental information acquired during related drug discovery campaigns against other aspartyl proteases. This knowledge base was brought to full f

The Discovery of YM-60828: A Potent, Sel

The Discovery of YM-60828: A Potent, Selective and Orally-Bioavailable Factor Xa Inhibitor

✍ Fukushi Hirayama; Hiroyuki Koshio; Naoko Katayama; Hiroyuki Kurihara; Yuta Taniu 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 351 KB

ChemInform Abstract: The Discovery of YM

ChemInform Abstract: The Discovery of YM-60828: A Potent, Selective and Orally-Bioavailable Factor Xa Inhibitor.

✍ Fukushi Hirayama; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 1 views

[Progress in Medicinal Chemistry] Progre

[Progress in Medicinal Chemistry] Progress in Medicinal Chemistry Volume 46 Volume 46 || 1 The Discovery of Raltegravir, an Integrase Inhibitor for the Treatment of HIV Infection

✍ Rowley, Michael 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 29 KB

Discovery of a Potent, Selective, and Or

Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer

✍ Dorsey, Bruce D.; Iqbal, Mohamed; Chatterjee, Sankar; Menta, Ernesto; Bernardini 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 161 KB